Penumbra, Inc.
@penumbrainc
Followers
4K
Following
122
Media
498
Statuses
878
Penumbra, Inc. is a global healthcare company focused on innovative therapies that address challenging medical conditions & unmet needs. https://t.co/xRiyE2Rcn1
Alameda, CA
Joined February 2017
Stories like Elizabeth’s help raise awareness of blood clot risks, especially for pregnant women. Take a moment to read her experience and learn the signs that could save a life: https://t.co/j6qXghVRMU
#PatientVoices #MedTech #MedDevice #PE #Innovation #CAVT @TODAYshow
today.com
The mother of four says her symptoms came on suddenly.
1
0
3
Hear from Dr. @roblookstein, Co-Principal Investigator of the #STORM-PE #RCT, as he discusses the study’s primary endpoints and what these results mean for advancing PE treatment. Learn more here: https://t.co/PFxefvV2RF
#CAVT #MedTech #MedDevice #Innovation
0
2
6
Discover how, Lily Lim, senior territory manager combines bold choices with a passion for improving lives: https://t.co/CdPZNkMw68. Visit https://t.co/S6Kq5XGi5M to learn more about career opportunities.
0
0
0
US HCPs: He faked a heart attack to save his life. Now he’s helping change how we treat pulmonary embolism. Read Richard Davis’s story of survival, advocacy, and impact on the STORM-PE RCT trial: https://t.co/LM8oic7sO2
#STORMPE #RCT #CAVT #MedTech #MedDevice #PatientVoices
0
1
1
US HCPs: Get ready for a big week at #VEITH2025 in New York City! Join our expert faculty for podium presentations and interactive sessions featuring new data and cutting-edge innovation. #STORMPE #RCT #CAVT #RubyXL
0
5
8
US HCPs: New analyses from the STRIKE-PE study presented at #TCT2025 show that #CAVT tech was associated w/ improved functional outcomes & QOL for patients w/ intermediate & high risk #PE: https://t.co/0Tnym8z9hN Rx only. Risk: https://t.co/yoJC7MXdXQ Clinical results may vary
0
1
7
US HCPs: #STORMPE #RCT now published in @CircAHA! Backed by peer-reviewed level 1 evidence for the treatment of acute intermediate high-risk PE, #CAVT shows superior efficacy over AC alone. https://t.co/bOZnj21TaK Rx only. Risk: https://t.co/SILdiRZoH4 Clinical results may vary
0
7
11
Join us today for our 3rd Quarter Earnings Conference Call at 1:30pm PT / 4:30pm ET. For more information: https://t.co/EY6G5R2mTx.
0
0
1
Penumbra announces secondary results of the ground-breaking STORM-PE RCT at VIVA 2025. Read more here: https://t.co/7DrLNUf4AR.
#CAVT #MedTech #Innovation #STORMPE #RCT
0
7
16
US HCPs: #STORMPE #RCT challenges use of AC alone as the standard of care for acute intermediate high-risk PE. Thank you, investigators, patients, & their families, for helping advance care https://t.co/kO7AcUdE8b Rx only. Risk: https://t.co/SILdiRZWwC Clinical results may vary
0
9
15
On #WorldStrokeDay, we join forces with @slice_inr as a Diamond Partner to advance stroke care. Register for 7 expert-led episodes exploring the latest treatments and innovations: https://t.co/Siocictcj6.
#StrokeCare #Innovation #StrokeEducation
@penumbrainc joins SLICE Worldwide 2025 as a Diamond Partner! Join us online and explore the daily challenges of caring for stroke patients from the inside. 🗓️ October 29, World Stroke Day 📍 Online 👉 Register for free: https://t.co/xCLyO42rUE
0
2
1
US HCPs: Breaking News! #STORMPE #RCT brings level 1 evidence for acute intermediate high- risk PE. The first to show superior efficacy for #CAVT with comparable safety to AC. https://t.co/kO7AcUd6iD Rx only. Risk: https://t.co/SILdiRZoH4 Clinical results may vary
0
10
17
Penumbra announces the results of the landmark STORM-PE RCT Trial at #TCT2025. Read more here: https://t.co/51fIL6ohxy.
#CAVT #MedTech #Innovation #STORMPE #RCT
0
9
15
US HCPs: Don’t miss our packed #TCT2025 schedule, featuring Penumbra on the podium and in interactive sessions throughout the week. Check out the events below with expert speakers in the field! Rx only. Risk: https://t.co/SILdiRZoH4 Clinical results may vary
0
3
9
US HCPs: #CAVT is the most advanced treatment for PE. #LightningFlash Rx only. Risk: https://t.co/SILdiRZoH4 Clinical results may vary
0
1
8
US HCPs: This #WorldThrombosisDay, we raise awareness about life-threatening blood clots and the innovations that help address them. Elizabeth’s story reminds us how awareness and quick action can save lives. Read more here: https://t.co/v5kVUrHEyx
#CAVT #MedTech #Innovation
penumbrainc.com
Elizabeth Simmons was 27 and pregnant when she was struck with a life-threatening pulmonary embolism. Her fourth pregnancy had been generally uncomplicated.
0
4
8
Introducing Penumbra's latest innovation, #SwiftSET Coil — expanding the procedural capabilities of the Swift Coil System. Read more here: https://t.co/1Z44Uo1LVr.
0
0
1
🩺Penumbra and @isth launched a new Thrombosis Management Toolkit, offering resources for both healthcare professionals and patients including essential info on managing thrombosis and more! Read more here: https://t.co/mqJRQ2nlVN
#VTEcare #WorldThrombosisDay #PatientEducation
worldthrombosisday.org
Chapel Hill, N.C., United States, September 17, 2025 — The World Thrombosis Day campaign, led by the International Society on Thrombosis and Haemostasis (ISTH), together with Penumbra, Inc., today...
📥New resource just in time for #WorldPatientSafetyDay! Explore our Thrombosis Management Options guide. This downloadable resource—supported by Penumbra—offers practical insights and evidence-based info for thrombosis management. 👉 https://t.co/W8K9ibSXr8
1
4
7
US HCPs: Our recent article in @EVToday explores the four Science-Based Aspiration (S-BAT) principles that guide safe and effective neuro thrombectomy. Read more here: https://t.co/Eucs4mqo1k Rx only. Risk: https://t.co/yoJC7MXdXQ Clinical results may vary. #SBAT #Innovation
0
0
1